| Fund ID | 805-4697368075 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 67% |
| Owned by non-U.S. persons | 0% |
| Fund | Type | Gross assets |
|---|---|---|
| Jll Partners Fund VII, L.P. | Private Equity | $1.42B |
| Jll Partners Fund VIII, L.P. | Private Equity | $974.7M |
| Jll Partners Fund VII Secondary (s) II, L.P. | Private Equity | $558.2M |
Jll Medplast Topco, LP reports $100 million in gross assets, among the top 42% of private funds by size.
Jll Medplast Topco, LP is managed by Jll Partners LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.